Literature DB >> 8082724

Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.

L Sun1, S Wu, K Coleman, K C Fields, L E Humphrey, M G Brattain.   

Abstract

Although a great deal is known about the cellular effects of exogenous transforming growth factor-beta (TGF-beta) treatment and the effects of various exogenous agents (including TGF-beta's themselves) on TGF-beta expression, studies of cellular controls for autocrine TGF-beta expression and function have been rare. Since exogenous TGF-beta treatment blocks progression through the cell cycle, it seemed likely that autocrine TGF-beta activity would be induced by growth states in which there was little or no cell division such as confluency or quiescence. Specific TGF-beta 1 or beta 2 neutralizing antibody treatment of a colon carcinoma cell line designated CBS showed that autocrine TGF-beta activity could be demonstrated in quiescent cells but not in preconfluent cells. Studies of kinetics of TGF-beta 1 and beta 2 mRNA levels during the establishment of quiescence revealed a significant increase of both isoforms in quiescent cells. The quiescent cells also secreted three- to fourfold and four-to fivefold higher levels of total (latent plus active) TGF-beta 1 and beta 2 protein in the conditioned media than the confluent cells and preconfluent cells, respectively. There was no detectable active form of either TGF-beta isoform in the conditioned media of preconfluent cells, whereas a significant amount of active TGF-beta 1 and beta 2 was detected in the conditioned media of quiescent cells. Quantitative RNase protection assays were developed to compare the effects of cell crowding vs quiescence on TGF-beta expression. TGF-beta 1 was primarily induced by quiescence. TGF-beta 2 was induced by both quiescence and cell crowding. Increased TGF-beta 1 mRNA levels appeared to be exclusively due to an increase in stability, while increased TGF-beta 2 mRNA levels were due to increased transcription. This growth state-related induction of TGF-beta's was also observed in two other colon carcinoma cell lines. These studies show that TGF-beta 1 and beta 2 are autocrine-negative factors which can be situationally expressed by cells as a function of their growth state. Autocrine expression of the TGF-beta's in this model system appears not to affect exponentially growing cells, but rather to function by maintaining a quiescent state and/or by blocking progression through the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082724     DOI: 10.1006/excr.1994.1251

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.

Authors:  P Hausner; D J Venzon; L Grogan; I R Kirsch
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Human intestinal epithelial cells down-regulate IL-8 expression in human intestinal microvascular endothelial cells; role of transforming growth factor-beta 1 (TGF-beta1).

Authors:  N Lügering; T Kucharzik; H Gockel; C Sorg; R Stoll; W Domschke
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

3.  Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10.

Authors:  T Kucharzik; N Lügering; G Winde; W Domschke; R Stoll
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

4.  WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.

Authors:  Xiao-Qiong Liu; Ashwani Rajput; Liying Geng; Melanie Ongchin; Anathbandhu Chaudhuri; Jing Wang
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

5.  Particled Mica, STB-HO has chemopreventive potential via G1 arrest, and inhibition of proliferation and vascular endothelial growth factor receptor 2 in HCT colorectal cancer cells.

Authors:  Sung-Yun Cho; Hyo-Jeong Lee; Sun-Mi Cho; Bonglee Kim; Yeon Kwon Jung; Sung-Hoon Kim
Journal:  BMC Complement Altern Med       Date:  2013-07-24       Impact factor: 3.659

6.  COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway.

Authors:  Yan Wang; Guangmei Xie; Min Li; Juan Du; Min Wang
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.